Summary
173.53 -0.34(-0.19%)07/26/2024
PTC Inc (PTC)
PTC Inc (PTC)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
-0.25 | -1.36 | -2.30 | -4.12 | -3.92 | 20.35 | 136.55 | 9,419.50 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
Trading Data | ||
Close | 173.53 | |
Open | 174.95 | |
High | 176.77 | |
Low | 173.50 | |
Volume | 602,052 | |
Change | -0.43 | |
Change % | -0.25 | |
Avg Volume (20 Days) | 805,851 | |
Volume/Avg Volume (20 Days) Ratio | 0.75 | |
52 Week Range | 134.61 - 194.18 | |
Price vs 52 Week High | -10.63% | |
Price vs 52 Week Low | 28.92% | |
Range | -0.81 | |
Gap Up/Down | -1.04 |
Fundamentals | ||
Market Capitalization (Mln) | 20,812 | |
EBIDTA | 607,523,968 | |
PE Ratio | 75.3138 | |
PEG Ratio | 1.8485 | |
WallStreet Target Price | 203.24 | |
Book Value | 24.5840 | |
Earnings Per Share | 2.3900 | |
EPS Estimate Current Quarter | 1.2300 | |
EPS Estimate Next Quarter | 1.2100 | |
EPS Estimate Current Year | 4.9200 | |
EPS Estimate Next Year | 5.8100 | |
Diluted EPS (TTM) | 2.3900 | |
Revenues | ||
Profit Marging | 0.1284 | |
Operating Marging (TTM) | 0.2982 | |
Return on asset (TTM) | 0.0533 | |
Return on equity (TTM) | 0.1054 | |
Revenue TTM | 2,242,247,936 | |
Revenue per share TTM | 18.8420 | |
Quarterly Revenue Growth (YOY) | 0.1120 | |
Quarterly Earnings Growth (YOY) | 0.7920 | |
Gross Profit (TTM) | 1,656,047,000 |
Dividends | ||
Dividend Share | 0.0000 | |
Dividend Yield | ||
Valuations | ||
Trailing PE | 75.3138 | |
Forward PE | 38.0228 | |
Price Sales (TTM) | 0.0000 | |
Price Book (MRQ) | 7.6698 | |
Revenue Enterprise Value | 10.8705 | |
EBITDA Enterprise Value | 38.0703 | |
Shares | ||
Shares Outstanding | 119,744,000 | |
Shares Float | 112,365,619 | |
Shares Short | 0 | |
Shares Short (Prior Month) | 0 | |
Shares Ratio | 0.00 | |
Short Outstanding (%) | 0.00 | |
Short Float (%) | 0.02 | |
Insider (%) | 6.10 | |
Institutions (%) | 97.60 |
07/26 10:30 EST - globenewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
07/25 16:30 EST - prnewswire.com
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
WARREN, N.J. , July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Aug. 8, at 4:30 p.m.
PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results
WARREN, N.J. , July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Aug. 8, at 4:30 p.m.
07/24 11:06 EST - zacks.com
PTC Inc. (PTC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
PTC Inc. (PTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PTC Inc. (PTC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
PTC Inc. (PTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/19 13:16 EST - zacks.com
Why PTC Inc. (PTC) Could Beat Earnings Estimates Again
PTC Inc. (PTC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why PTC Inc. (PTC) Could Beat Earnings Estimates Again
PTC Inc. (PTC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
07/12 15:20 EST - globenewswire.com
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
NEW YORK, July 12, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PTC Therapeutics, Inc. (“PTC” or the “Company”) (NASDAQ: PTCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
07/12 15:02 EST - seekingalpha.com
PTC: A Bullish Bet With ServiceMax Integration Boost
PTC Inc. provides lifecycle management software and services globally. The global PLM market is expected to grow at a CAGR of 8.6% from 2022 to 2030, with PTC competing with major industry players. PTC has shown revenue and earnings growth, and strong free cash flow.
PTC: A Bullish Bet With ServiceMax Integration Boost
PTC Inc. provides lifecycle management software and services globally. The global PLM market is expected to grow at a CAGR of 8.6% from 2022 to 2030, with PTC competing with major industry players. PTC has shown revenue and earnings growth, and strong free cash flow.
07/11 08:00 EST - prnewswire.com
PTC to Announce Fiscal Q3'24 Results on Wednesday, July 31st, 2024
BOSTON , July 11, 2024 /PRNewswire/ -- PTC (Nasdaq: PTC) will release its fiscal 2024 third quarter results on Wednesday, July 31 st after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, July 31 st at 5pm Eastern Time.
PTC to Announce Fiscal Q3'24 Results on Wednesday, July 31st, 2024
BOSTON , July 11, 2024 /PRNewswire/ -- PTC (Nasdaq: PTC) will release its fiscal 2024 third quarter results on Wednesday, July 31 st after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, July 31 st at 5pm Eastern Time.
07/10 10:00 EST - accesswire.com
Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for PTC Therapeutics, Inc to Lead the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.
Bronstein, Gewirtz and Grossman, LLC sends a Class Action Lawsuit reminder to shareholder investors for PTC Therapeutics, Inc to Lead the Class Action Lawsuit!
NEW YORK CITY, NY / ACCESSWIRE / July 10, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/PTCT.
07/03 09:20 EST - zacks.com
PTC Stock Surges 30% in a Year: Will the Momentum Continue?
PTC's performance gains from solid momentum across the PLM and CAD business segments.
PTC Stock Surges 30% in a Year: Will the Momentum Continue?
PTC's performance gains from solid momentum across the PLM and CAD business segments.
06/28 09:30 EST - investorplace.com
3 Robotics Stocks That Could Make Your Grandchildren Rich
The best robotics stocks to buy are those that will continue to attract investors who are trying to future-proof their portfolios. That's because the market could to grow 15.91% from $45.85 billion in 2024 to $95.93 billion in 2029.
3 Robotics Stocks That Could Make Your Grandchildren Rich
The best robotics stocks to buy are those that will continue to attract investors who are trying to future-proof their portfolios. That's because the market could to grow 15.91% from $45.85 billion in 2024 to $95.93 billion in 2029.
06/27 06:51 EST - fool.com
1 Long-Term Growth Stock to Buy Hand Over Fist and 1 to Avoid
Automation is the future of manufacturing, and this company has a bright future, but its management needs to restore confidence in its guidance. This industrial software provider is about to start generating some serious cash flow.
1 Long-Term Growth Stock to Buy Hand Over Fist and 1 to Avoid
Automation is the future of manufacturing, and this company has a bright future, but its management needs to restore confidence in its guidance. This industrial software provider is about to start generating some serious cash flow.